CLINICAL ROLE -
Cost-Utility Analysis of Treatments for Advanced Non-Small Cell Lung Cancer
A national community-level study of Medicare patients with advanced non-small cell lung cancer found that adding targeted therapy to chemotherapy regimens was not cost-effective.
Read More